SCHEMBL17895651

SCHEMBL17895651

CCCC(O)(c1cncc(Cl)c1)c1nc2ccc(Br)cc2s1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.36
▸ NPC1 O15118 5/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ PPARA Q07869 2/20 0.36
▸ CASR P41180 4/20 0.36
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2D6 P10635 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ APP P05067 2/20 0.33
▸ CSNK1D P48730 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17895681 0.91 NPC1 (0.38) RAB9ANPC1CYP1A2CYP2C9CYP2C19
SCHEMBL17895688 0.86 PIK3CG (0.38) RAB9ANPC1CYP1A2CYP2C9CYP2C19
SCHEMBL17895599 0.85 PPARA (0.38) RAB9ANPC1CYP1A2CYP2C9CYP2C19
SCHEMBL17895558 0.85 RORC (0.37) RAB9ANPC1CYP1A2CYP2C9CYP2C19
SCHEMBL17895611 0.84 PIK3CA (0.39) RAB9ANPC1CYP1A2CYP2C9CYP2C19
SCHEMBL17895701 0.78 TUBB4A (0.36) RAB9ANPC1DYRK1APPARACASR
SCHEMBL17895608 0.78 PIK3CG (0.39) RAB9ANPC1CYP1A2CYP2C9CYP2C19
SCHEMBL17895705 0.76 RORC (0.39) RAB9ANPC1CYP1A2CYP2C9CYP2C19
SCHEMBL17895719 0.75 PPARA (0.36) RAB9ANPC1CYP1A2CYP2C9CYP2C19
SCHEMBL17895612 0.75 CSNK1D (0.41) RAB9ANPC1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107531631-B Methods and agents for treating diseases 安吉昂生物医药公司 2021-09-03 — — CN claimed
EP-3240778-A1 METHODS AND AGENTS FOR TREATING DISEASE Angion Biomedica Corp. (US) 2017-11-08 — — EP claimed
WO-2016109492-A1 METHODS AND AGENTS FOR TREATING DISEASE ANGION BIOMEDICA CORP (US) 2016-07-07 — — WO claimed
CN-107531631-B Methods and agents for treating diseases 安吉昂生物医药公司 2021-09-03 — — CN disclosed
EP-3240778-A1 METHODS AND AGENTS FOR TREATING DISEASE Angion Biomedica Corp. (US) 2017-11-08 — — EP disclosed
WO-2016109492-A1 METHODS AND AGENTS FOR TREATING DISEASE ANGION BIOMEDICA CORP (US) 2016-07-07 — — WO disclosed
Send feedback